- Home
- MOLN vs TWIN Comparison
MOLN vs TWIN Comparison
Compare MOLN & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- TWIN
- Stock Information
- Founded
- MOLN 2004
- TWIN 1918
- Country
- MOLN Switzerland
- TWIN United States
- Employees
- MOLN N/A
- TWIN N/A
- Industry
- MOLN
- TWIN Industrial Machinery/Components
- Sector
- MOLN
- TWIN Industrials
- Exchange
- MOLN Nasdaq
- TWIN Nasdaq
- Market Cap
- MOLN 139.5M
- TWIN 186.2M
- IPO Year
- MOLN 2021
- TWIN N/A
- Fundamental
- Price
- MOLN $3.92
- TWIN $14.45
- Analyst Decision
- MOLN Hold
- TWIN Strong Buy
- Analyst Count
- MOLN 1
- TWIN 1
- Target Price
- MOLN $4.00
- TWIN $12.00
- AVG Volume (30 Days)
- MOLN 2.5K
- TWIN 39.9K
- Earning Date
- MOLN 11-05-2025
- TWIN 11-05-2025
- Dividend Yield
- MOLN N/A
- TWIN 1.11%
- EPS Growth
- MOLN N/A
- TWIN N/A
- EPS
- MOLN N/A
- TWIN N/A
- Revenue
- MOLN $856,302.00
- TWIN $340,738,000.00
- Revenue This Year
- MOLN N/A
- TWIN $10.79
- Revenue Next Year
- MOLN $1,000.00
- TWIN $8.43
- P/E Ratio
- MOLN N/A
- TWIN N/A
- Revenue Growth
- MOLN N/A
- TWIN 15.46
- 52 Week Low
- MOLN $3.36
- TWIN $6.16
- 52 Week High
- MOLN $7.60
- TWIN $15.12
- Technical
- Relative Strength Index (RSI)
- MOLN 56.78
- TWIN 56.46
- Support Level
- MOLN $3.70
- TWIN $14.11
- Resistance Level
- MOLN $3.81
- TWIN $15.00
- Average True Range (ATR)
- MOLN 0.09
- TWIN 0.65
- MACD
- MOLN 0.01
- TWIN -0.09
- Stochastic Oscillator
- MOLN 79.97
- TWIN 52.84
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.